Kaleido Biosciences Inc achieved in the fourth quarter 2021, above Company average Revenue surge of 105% year on year, to $ 0.49 millions.
Looking into fourth quarter 2021 results within Biotechnology & Pharmaceuticals industry 63 other companies have achieved higher Revenue growth. While Kaleido Biosciences Inc ' s Revenue doubling of 105% ranks overall at the positon no. 3695 in the fourth quarter 2021.
Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021
Kaleido Biosciences Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
92.8 %
-0.77 %
-50.71 %
(Sep 30 2020)
KLDO's IV. Quarter Q/Q Revenue Comment
Kaleido Biosciences Inc achieved in the IV. Quarter 2021 above company average sequential Revenue doubling of 392%, to $ 0.49 millions, from $0.10 millions in the third quarter. KLDO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 45 other companies have achieved higher Revenue quarter on quarter growth. While Kaleido Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 1549.
Kaleido Biosciences Inc achieved in the IV. Quarter 2021 above company average sequential Revenue doubling of 392%, to $ 0.49 millions, from $0.10 millions in the third quarter. KLDO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 45 other companies have achieved higher Revenue quarter on quarter growth. While Kaleido Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 1549.
Kaleido Biosciences Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Dec 31 2021)
12 Months Ending (Sep 30 2021)
12 Months Ending (Jun 30 2021)
12 Months Ending (Mar 31 2021)
12 Months Ending (Dec 31 2020)
Cumulative Revenue 12 Months Ending
$ 1.10
$ 0.86
$ 1.23
$ 1.27
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
29.12 %
-30.66 %
-3.07 %
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 3971
# 2833
# 0
# 0
# 0
Cumulative Revenue growth Comment
Kaleido Biosciences Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 105% year on year, to $ 1 millions if the fiscal year would have ended in Dec 31 2021. Kaleido Biosciences Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2021. And, Kaleido Biosciences Inc realized the fastest Revenue growth, in Biotechnology & Pharmaceuticals industry. But from twelve months ended Sep 30 2021 rise was beneth at 29.12 % from $0.86 millions achieved in the period from Sep 30 2021 to Dec 31 2020. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -16.46%. The momentum is even more impressive from twelve months ended Sep 30 2021 exhibited at 29.12 % increase from $0.86 millions in the period from Sep 30 2021 to Dec 31 2020.
Kaleido Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Kaleido Biosciences Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 105% year on year, to $ 1 millions if the fiscal year would have ended in Dec 31 2021. Kaleido Biosciences Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Sep 30 2021. And, Kaleido Biosciences Inc realized the fastest Revenue growth, in Biotechnology & Pharmaceuticals industry. But from twelve months ended Sep 30 2021 rise was beneth at 29.12 % from $0.86 millions achieved in the period from Sep 30 2021 to Dec 31 2020. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -16.46%. The momentum is even more impressive from twelve months ended Sep 30 2021 exhibited at 29.12 % increase from $0.86 millions in the period from Sep 30 2021 to Dec 31 2020.
Kaleido Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Kaleido Biosciences Inc Revenue Growth Rates (KLDO), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
175.00%